WMT

122.82

-3.97%↓

155.36

-1.48%↓

77.24

-1.3%↓

171.46

-4.2%↓

PEP

162.65

-1.28%↓

WMT

122.82

-3.97%↓

155.36

-1.48%↓

77.24

-1.3%↓

171.46

-4.2%↓

PEP

162.65

-1.28%↓

WMT

122.82

-3.97%↓

155.36

-1.48%↓

77.24

-1.3%↓

171.46

-4.2%↓

PEP

162.65

-1.28%↓

WMT

122.82

-3.97%↓

155.36

-1.48%↓

77.24

-1.3%↓

171.46

-4.2%↓

PEP

162.65

-1.28%↓

WMT

122.82

-3.97%↓

155.36

-1.48%↓

77.24

-1.3%↓

171.46

-4.2%↓

PEP

162.65

-1.28%↓

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Atidarymo kaina

18.65 -2.3

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

18.8

Max

19.25

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	13M 226M
P/E Sektoriaus vid.	34.638 32.206
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	16M 28M

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-15M 367M
Ankstesnė atidarymo kaina	20.95
Ankstesnė uždarymo kaina	18.65

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-04 23:39; UTC

Karštos akcijos

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

2026-03-04 23:20; UTC

Uždarbis

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

2026-03-04 21:43; UTC

Uždarbis

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

2026-03-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-04 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

2026-03-04 23:24; UTC

Rinkos pokalbiai

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy 4Q EPS C$2.86 >VET

2026-03-04 22:04; UTC

Rinkos pokalbiai

RBA Slipping Behind The Curve On Rates -- Market Talk

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Rev $66.8M >LAC

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Loss/Shr 52c >LAC

2026-03-04 21:52; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:50; UTC

Uždarbis

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026-03-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q Rev $165.2M >BULL

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q EPS 1c >BULL

2026-03-04 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-04 21:45; UTC

Rinkos pokalbiai

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

2026-03-04 21:40; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:36; UTC

Svarbiausios naujienos

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

2026-03-04 21:27; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:17; UTC

Rinkos pokalbiai

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

2026-03-04 21:16; UTC

Uždarbis

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q EPS $1.50 >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Net $7.35B >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Rev $19.31B >AVGO

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.